Invention Grant
- Patent Title: Crystal form of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d
-
Application No.: US17587374Application Date: 2022-01-28
-
Publication No.: US12129245B2Publication Date: 2024-10-29
- Inventor: Victor W. Rosso
- Applicant: Bristol-Myers Squibb Company
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agency: Covington & Burling LLP
- Main IPC: C07D403/12
- IPC: C07D403/12
Abstract:
Disclosed is crystalline Form E of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl) amino)-N-(methyl-d3)pyridazine-3-carboxamide. Form E is a neat crystalline form. Characterization data for Form E are disclosed.
Public/Granted literature
Information query
